Skip to main content
BioSenic SA logo

BioSenic SA — Investor Relations & Filings

Ticker · BIOS ISIN · BE0974280126 LEI · 549300HFIIMTOP1DFR76 BR Professional, scientific and technical activities
Filings indexed 968 across all filing types
Latest filing 2018-06-21 Proxy Solicitation & In…
Country BE Belgium
Listing BR BIOS

About BioSenic SA

http://www.biosenic.com/

BioSenic SA is a biotechnology company focused on developing innovative treatments for autoimmune diseases, inflammatory conditions, and bone disorders. The company's core activities are centered on two main technology platforms: one based on arsenic trioxide (ATO) for its immunomodulatory properties, and another involving allogeneic cell therapy for tissue repair and regeneration. BioSenic's objective is to address significant unmet medical needs in the fields of regenerative and immune medicine by advancing its clinical assets through development.

Recent filings

Filing Released Lang Actions
BT_2018-06-21_AGE_Convocation_EN.pdf
Proxy Solicitation & Information Statement Classification · 98% confidence The document is explicitly titled 'INVITATION TO THE EXTRAORDINARY GENERAL SHAREHOLDERS' MEETING' and details the agenda, proposed resolutions, voting procedures, and admission requirements for a meeting scheduled for July 9, 2018. This content is characteristic of materials sent to shareholders to solicit their attendance and votes for a general meeting. This aligns perfectly with the definition of Proxy Solicitation & Information Statement (PSI), which covers materials for general meetings. While it is an invitation to a meeting, the detailed resolutions and procedural information make it more specific than a general 'AGM-R' (which usually implies presentations/materials *from* the meeting) or a simple 'DEF 14A' (which focuses narrowly on remuneration). Since it solicits votes and provides detailed information for the meeting, PSI is the most accurate fit.
2018-06-21 English
BT_2018-06-21_AGE_Procuration_FR.pdf
Proxy Solicitation & Information Statement Classification · 99% confidence The document is titled 'PROCURATION' (Proxy) and contains a form for an actionnaire (shareholder) to designate a representative ('mandataire') to attend and vote at an 'assemblée générale extraordinaire' (Extraordinary General Meeting - EGM) scheduled for July 9, 2018. It details the agenda items, which include capital reduction, renewal of authorized capital, and approval of a new warrant plan. This document is explicitly designed to solicit shareholder votes and provide information necessary for voting at a general meeting, which aligns perfectly with the definition of Proxy Solicitation & Information Statement (PSI). It is not the final results (DVA), nor the meeting presentation (AGM-R), but the material used to gather votes beforehand.
2018-06-21 French
BT_2018-06-21_AGE_Procuration_EN.pdf
Proxy Solicitation & Information Statement Classification · 99% confidence The document is explicitly titled 'PROXY FORM' and contains detailed instructions for shareholders on how to appoint a proxy holder to vote on specific resolutions at an upcoming 'annual general meeting' (AGM) scheduled for July 9, 2018. The content includes the agenda, proposed resolutions (related to capital reduction, authorized capital renewal, and warrant plans), and voting instructions. This material is designed to solicit shareholder votes ahead of a general meeting, which aligns perfectly with the definition of Proxy Solicitation & Information Statement (PSI). It is not the AGM presentation itself (AGM-R), nor is it a full annual report (10-K) or a simple earnings release (ER).
2018-06-21 English
BT_2018-06-01_AGO-AGE 2018_Rapport special Conseil Administration_FR_Addendum.pdf
Capital/Financing Update Classification · 95% confidence The document is titled "ADDENDUM AU RAPPORT SPECIAL DU CONSEIL D'ADMINISTRATION ETABLI CONFORMEMENT AUX ARTICLES 583, 596 ET 598 DU CODE DES SOCIETES" (Addendum to the Special Report of the Board of Directors established in accordance with Articles 583, 596 and 598 of the Companies Code). It explicitly states that it is an addendum to a previously issued 'Rapport Spécial' (Special Report) and provides clarifications regarding the issuance of Warrants, including detailed financial tables showing dilution and capital structure changes. This document is not the initial Earnings Release (ER), a full Annual Report (10-K), or a standard Interim Report (IR). It is a specific report detailing governance/board actions related to capital structure changes (Warrants/Share issuance) and is presented as a formal report supplement. Given the focus on the Board's special report and the detailed financial implications of a capital event (warrants), it aligns best with a specialized report or governance document. Since it is an addendum to a 'Special Report' concerning capital instruments (Warrants), it relates closely to capital structure changes. However, the core content is the modification/clarification of a formal report required by corporate law regarding shareholder rights and capital structure. The closest fit among the provided codes is 'CAP' (Capital/Financing Update) due to the extensive discussion of warrants, dilution, and capital structure changes, or potentially 'CGR' (Governance Information) as it amends a Board report. Given the heavy emphasis on the financial mechanics of the warrants and dilution calculations, 'CAP' is the most appropriate classification for this specific financial/structural update document, even though it is framed as an addendum to a special report.
2018-06-21 French
BT_2018-06-21_AGE_Droits actionnaires_EN.pdf
AGM Information Classification · 98% confidence The document explicitly discusses the rights of shareholders to ask questions in writing prior to an Extraordinary General Meeting (EGM) scheduled for July 9, 2018. It details the deadlines and procedures for submitting these questions. This content is directly related to shareholder participation and information rights concerning a general meeting, which aligns closely with the purpose of Proxy Solicitation & Information Statements (PSI), which cover materials sent to shareholders to provide information and request votes for meetings. While it is not a proxy statement itself, it is a formal notice detailing shareholder rights related to an upcoming meeting, making PSI the most appropriate fit among the specific options, as it deals with pre-meeting shareholder information/rights.
2018-06-21 English
BT_2018-06-21_AGE_Droits actionnaires_FR.pdf
AGM Information Classification · 98% confidence The document is titled 'INFORMATIONS SUR LE DROIT DES ACTIONNAIRES DE POSER DES QUESTIONS A L'OCCASION DE L'ASSEMBLEE GENERALE EXTRAORDINAIRE' (Information on the right of shareholders to ask questions at the Extraordinary General Meeting). It details the procedures, deadlines (June 25, July 3, July 9, 2018), and conditions for shareholders to submit written questions prior to an Extraordinary General Meeting (EGM). This content directly relates to shareholder rights and procedures surrounding a general meeting, which aligns best with the 'AGM Information' category, even though it specifies an EGM rather than an AGM, as it concerns meeting procedures and shareholder interaction. It is not a full report (10-K, IR), a proxy statement (PSI), or a declaration of voting results (DVA), but rather procedural information related to the meeting itself.
2018-06-21 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.